CXCR4 and cancer: However, the application of pentixafor to β–-emitting routinely used radionuclides such as lutetium-177 (177Lu) and yttrium-90 (90Y) for cancer endoradiotherapy is inappropriate due to the reduction in CXCR4-binding affinities30.